JY
RLAY icon

Jeff Yass’s Relay Therapeutics RLAY Stock Holding History

Jeff Yass’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$956K Buy
+51,100
New +$742K ﹤0.01% 8321
2025
Q4 		– Sell
-17,600
Closed -$91.9K – 13408
2025
Q3 		$91.9K Buy
+17,600
New +$67.1K ﹤0.01% 11614
2024
Q4 		– Sell
-62,300
Closed -$441K – 13050
2024
Q3 		$441K Buy
+62,300
New +$465K ﹤0.01% 8773
2023
Q3 		– Sell
-67,000
Closed -$842K – 12817
2023
Q2 		$842K Buy
67,000
+51,600
+335% +$642K ﹤0.01% 7092
2023
Q1 		$254K Sell
15,400
-23,800
-61% -$427K ﹤0.01% 10086
2022
Q4 		$586K Sell
39,200
-43,000
-52% -$823K ﹤0.01% 7433
2022
Q3 		$1.84M Sell
82,200
-14,700
-15% -$323K ﹤0.01% 5087
2022
Q2 		$1.62M Buy
96,900
+89,900
+1,284% +$1.93M ﹤0.01% 5352
2022
Q1 		$210K Buy
7,000
+200
+3% +$4.85K ﹤0.01% 11126
2021
Q4 		$209K Sell
6,800
-17,600
-72% -$556K ﹤0.01% 11356
2021
Q3 		$769K Buy
+24,400
New +$821K ﹤0.01% 8239

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jeff Yass's RLAY Position: Q2 2026 in Review

Jeff Yass reduced its Relay Therapeutics (RLAY) stake by 34% in Q2 2026, selling an estimated $735K and leaving 96,549 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #6725.

Jeff Yass first reported a position in RLAY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.2M in Q1 2023. 257 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Jeff Yass held 96,549 shares of Relay Therapeutics worth $1.81M as of Q2 2026.
  • Jeff Yass sold 50,609 Relay Therapeutics shares in Q2 2026, an estimated $735K.
  • Relay Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6725 holding.
  • Jeff Yass first reported a position in Relay Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Jeff Yass's Relay Therapeutics position peaked at $4.2M in Q1 2023.
  • 257 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.